2009
DOI: 10.1016/j.jcin.2008.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography

Abstract: The Amplatzer PFO Occluder affords excellent safety and long-term clinical efficacy of percutaneous PFO closure without intraprocedural echocardiography.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
54
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 81 publications
(63 citation statements)
references
References 37 publications
6
54
0
1
Order By: Relevance
“…Complete PFO closure is reported in 51-100% of patients [23], depending on device type and methodology used (transcranial Doppler, transoesophageal or transthoracic echocardiography), and the yearly recurrence rates of ischaemic strokes and transient ischaemic attacks (TIAs) vary between 0-5% [7].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Complete PFO closure is reported in 51-100% of patients [23], depending on device type and methodology used (transcranial Doppler, transoesophageal or transthoracic echocardiography), and the yearly recurrence rates of ischaemic strokes and transient ischaemic attacks (TIAs) vary between 0-5% [7].…”
Section: Discussionmentioning
confidence: 99%
“…Anatomical and physiological differences between PFOs and atrial septal defects led to the development of devices specifically designed for percutaneous PFO closure. Current devices for percutaneous PFO closure, such as the Amplatzer PFO Occluder, achieve complete PFO occlusion in >90% of cases with complication rates <1% and yearly recurrence rates <1% [23]. This improvement in device performance is likely to positively impact clinical outcome.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This benchmark of effective closure was met in only 86%, a rate of closure that is less than what has been reported with contemporary devices such as the Amplatzer PFO occluder. 8 It should be noted that according to the CLOSURE I protocol, a shunt of grade 1 could be part of a successful procedural outcome and also was an inclusion criterion sufficient to be enrolled into the study. According to Furlan et al, 2 of the 909 subjects in the study, 428 (47%) had a "trace" shunt of 1 to 10 bubbles at baseline.…”
Section: Wrong Devicementioning
confidence: 99%
“…37 Ongoing randomized, controlled trials will provide the best evidence on the safety and efficacy of transcatheter patent foramen ovale closure relative to antithrombotic therapy. 37 Although highly experienced centres have demonstrated successful transcatheter closure of patent foramen ovale with only fluoroscopic guidance, 41 the combination of fluoroscopy and echocardiography (transoesophageal or intracardiac) may constitute the best approach to achieve the highest success rate while minimizing the complications rate. 42 The interventional procedure is similar to the ASD closure procedure.…”
Section: Transcatheter Closure Of Atrial Septal Defects and Patent Fomentioning
confidence: 99%